Managing the risk of venous thromboembolism in transgender adults undergoing hormone therapy

Introduction: Venous thromboembolism (VTE) is a potential risk of estrogen therapy. However, data show an improvement in the quality of life for transgender people who use feminizing hormone therapy. With few transgender-specific data, guidance may be drawn from cisgender (nontransgender) data, with...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldstein, Zil, Khan, Musaub, Reisman, Tamar, Safer, Joshua D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628137/
https://www.ncbi.nlm.nih.gov/pubmed/31372078
http://dx.doi.org/10.2147/JBM.S166780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628137/
https://www.ncbi.nlm.nih.gov/pubmed/31372078
http://dx.doi.org/10.2147/JBM.S166780

Ejemplares similares